BiotechTube
Home/LeonaBio/Mark Worthington, JD
MW

Mark Worthington, JD

General Counsel, Chief Compliance Officer & Corporate Secretary

LeonaBio

Therapeutic Areas

OncologyNeurology

LeonaBio Pipeline

DrugIndicationPhase
LasofoxifeneER+, ESR1-Mutant Metastatic Breast CancerPhase 3
ATH-1105Amyotrophic Lateral Sclerosis (ALS)Phase 1/2

Leadership Team at LeonaBio

ML
Mark Litton, PhD
President & Chief Executive Officer
JS
Javier San Martin, M.D.
Chief Medical Officer
KC
Kevin Church, PhD
Chief Scientific Officer
RR
Robert Renninger
Chief Financial Officer
KR
Kelly Romano
Chair of the Board
JE
Joseph Edelman
Board Member
View full LeonaBio profile